stockrow
Saturday 7 November 2026
Export OSRH’s income statement to Excel — free account
OSR Health, Inc.
OSRH Healthcare Biotechnology
OSR Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 million, down 17.7% from fiscal 2024.
- Revenue
- −72.2%
- EPS
- −200.0%
- Free cash flow
- −398.8%
- Total debt
- +28.2%
Quarter to June 2026, against a year earlier
0.15
0.01
+7.14%
Follow OSRH
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(22.63%) | (13.33%) | (7.36%) | (8.13%) | |
| (14.68%) | (10.40%) | (5.51%) | (6.10%) | ||
ROIC |
(6.22%) | (8.84%) | (9.12%) | (8.19%) | |
Return on Tangible Assets |
123.85% | 127.02% | 64.43% | 84.32% | |
Average Days of Receivables |
56.65 | 49.25 | 44.39 | 49.26 | |
Free Cash Flow per Share |
(0.16) | (0.18) | (0.17) | (0.22) | |
Free Cash Flow |
(3.44) | (4.76) | (5.27) | (7.20) | |
Capital Expenditures |
0.00 | (0.43) | — | — | |
| Other line items | |||||
Cash ROIC |
(2.44%) | (3.58%) | (3.93%) | (5.46%) | |
Accounts Receivable Turnover |
0.00 | 4.38 | 4.70 | 3.63 | |
Accounts Payable Turnover |
0.63 | 0.52 | 0.26 | 0.15 | |
Inventory Turnover |
0.00 | 4.14 | 3.41 | 2.95 | |
Average Days of Payables |
993.14 | 1,235.67 | 1,475.39 | 2,496.34 | |
Days of Inventory on Hand |
23.99 | 30.99 | 82.59 | 185.32 | |
Tax Rate |
(0.12) | (0.08) | (0.13) | (0.15) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
412.43% | 651.42% | 748.30% | 969.01% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(109.56) | (36.22) | (36.63) | (34.00) | |
Operating CF/Net income |
0.24 | 0.24 | 0.55 | 0.67 | |
Depreciation/Fixed assets |
83.23 | 55.03 | 61.62 | 66.55 | |
Capex/Depreciation |
0.00 | (0.05) | 0.00 | 0.00 | |
Revenue per Share |
0.16 | 0.11 | 0.08 | 0.06 | |
Operating CF per Share |
(0.16) | (0.17) | (0.17) | (0.22) | |
Capex per Share |
0.00 | (0.02) | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.15 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 26 Oct 2026